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WILDLIFE CONTRACEPTION: TARGETING THE OOCYTE 
 
RICHARD E. MAULDIN AND LOWELL A. MILLER, USDA, APHIS, Wildlife Services, National Wildlife 
 Research Center, Fort Collins, Colorado, USA 
 
Abstract: The USDA’s National Wildlife Research Center (NWRC) has successfully researched and 
developed a number of chemical and immunologically-based wildlife contraceptives.  Diazacon™ interferes 
with cholesterol metabolism and disrupts steroidogenesis, while nicarbazin (registered as OvoControl-P® and 
OvoControl-G®) disrupts the structure of the vitelline membrane of bird eggs. Immunologically-based agents 
act to stimulate targeted antibody production. GonaCon™ causes the host’s immune system to bind 
gonadotropin releasing hormone, preventing ovulation, while SpayVac™ prevents fertilization of the post-
ovulatory oocyte.  This kind of target specificity can be highly advantageous. A number of oocyte-only 
control contraceptive strategies are currently being researched at the NWRC.  4-Vinylcyclohexene diepoxide 
(VCD) is an industrial chemical which is specifically ovotoxic, depleting the ovarian oocyte pool with 
repeated exposure.   Research into VCD efficacy as well as the comparability of a similar diepoxide, ERL 
4221, in rats and pigs is in progress.  Immunological inhibition of recently discovered oocyte-secreted 
proteins which regulate follicular development in mammals is also of interest. Two such proteins, growth 
differentiation factor 9 (GDF9) and bone morphogenic protein 15 (BMP15), are highly specific targets for the 
suppression or elimination of folliculogenesis.  These oocyte-specific strategies may offer new, effective 
alternatives for wildlife contraception. 
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INTRODUCTION 
 For the last 15 years, the National Wildlife 
Research Center (NWRC) has been involved in the 
research and development of chemical and 
immunological contraceptive agents to control 
overabundant wildlife.  Chemical agents inhibit or 
diminish reproduction by exerting an effect which 
is not mediated by the organism’s immune system. 
These chemicals can be natural unmodified 
compounds, synthetic non-natural compounds, or 
biologically-produced molecules whose structures 
have been modified to alter their normal 
interactions in the body.  Immunologically-based 
agents act by eliciting a response from the immune 
system in the form of antibody production directed 
at a reproductively important target such as a 
hormone. These molecular targets do not, by 
themselves, possess the immunogenicity necessary 
to stimulate the immune system, so the molecule or 
a small, immunologically active portion of it (an 
epitope) must be linked or conjugated to a much 
larger molecule that the immune system will detect, 
identify as foreign, and produce antibodies against.  
Ideally, antibodies to the target compound are 
produced as a by-product of this process. The 
selection of this larger carrier molecule can be as 
important as the identification of the appropriate 
epitope of the target molecule. Normally, the 
conjugate is dissolved in a saline solution and 
aggressively mixed with an adjuvant (a mixture of 
surfactant and mineral oil) to form a thick 
emulsion. When injected, the appropriate adjuvant 
potentiates the immune system, enhancing the 
response to the conjugate without causing serious 
localized tissue damage. The adjuvant also serves 
to immobilize and extend the release of the 
conjugate, maximizing its immunogenicity. 
 Recently, increasing attention at the NWRC as 
well as other institutions worldwide has been given 
to the application of contraceptive agents and 
strategies to control escalating numbers of 
introduced or invasive species. Additionally, the 
NWRC is currently researching new approaches to 
wildlife contraception utilizing both chemical and 
immunogenic agents whose actions focus on the 
pre-fertilization oocyte. Hopefully, the use of these 
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agents will compliment the chemical/immunogenic 
products already developed by the NWRC for the 
contraception of problem wildlife, particularly 
invasive species. 
 
EXISTING CONTRACEPTIVE  
STRATEGIES 
DiazaCon™ 
 20,25 Diazacholesterol dihydrochloride (CAS# 
1249-84-9) was originally developed as a 
cholesterol-lowering drug for use in humans (Sachs 
and Wolfman 1965) and later investigated to 
determine its efficacy in reducing the cholesterol 
content in egg yolks for human consumption (Singh 
et al. 1972). The chemical 20,25-diazacholesterol 
dihydrochloride (Figure 1) is an analog of 
cholesterol, in which carbons in the 20 and 25 
positions have been replaced with nitrogen.  It acts 
by mimicking cholesterol and inhibiting the   24-  
reductase enzyme which converts desmosterol to 
cholesterol during the process of steroidogenesis 
(Ahrens et al. 1965, Ranney and Cook 1965).  This 
results in an increase in desmosterol and a 
corresponding decrease in cholesterol, which in 
turn reduces the concentrations of steroid sex 
hormones (e.g. testosterone and estrogen) that are 
critical for proper reproductive function.  Used 
under a variety of synonyms and trade names such 
as SC-12937 and ornitrol, 20,25-diazacholesterol 
has been investigated as a contraceptive in several 
bird species (Johnston et al. 2001a). Under the new 
trade name DiazaConTM, the NWRC has continued 
extensive research using 20,25-diazacholesterol as 
a contraceptive in birds and mammals. 
 Yoder et al. (2005) summarized a series of 
laboratory experiments performed at the NWRC 
using DiazaCon™ as a contraceptive in quail 
(Coturnix coturnix), ring-necked doves 
(Streptopelia risoria), brown headed cowbirds  
 
 
 
 
Figure 1.  Structural comparison of cholesterol and 20,25-diazacholesterol (Diazacon™).  Circled carbons in cholesterol 
are substituted with nitrogens in Diazacon™. 
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(Molothrus ater),  monk parakeets (Myiopsitta 
monachus), American crows (Corvus 
brachyrhyncus), and mallards (Anas 
platyrhynchos).  Serum levels of desmosterol and 
cholesterol as well as egg production (when 
possible) were assessed.  In all species, treated 
birds showed substantially higher levels of serum 
desmosterol and reduced levels of cholesterol in 
treated birds compared to controls. The direct effect 
of DiazaCon™ treatment on egg production and 
hatchability could not be assessed in cowbirds or 
crows, but treatment dramatically decreased egg 
production and hatchability in monk parakeets, 
mallards, and quail. Treated quail also exhibited 
decreases in female serum progesterone and male 
testosterone levels of 42% and 37%, respectively 
(C. Yoder, unpublished data). Increased serum 
desmosterol levels with a concomitant decrease in 
serum cholesterol concentrations may serve as a 
useful indicator of decreased reproductive potential 
in situations where adults can be captured and 
blood samples taken, but nests are inaccessible or 
adults will not breed in captivity.  
 The use of 20,25-diazacholesterol as a 
mammalian contraceptive has also been explored.  
Spermatogenesis was inhibited in both bandicoot 
rats (Bandicota bengalensis) injected with 20,25-
diazacholesterol at 100-200 mg kg-1 (Hikim and 
Chakraborty 1986, Hikim 1987) and in mice (Mus 
musculus) given 28 doses of 10, 20, or 30 mg kg-1 
(Singh and Chakravarty 2003).  Nash et al. (2007) 
found both a 47% decrease in reproductive success 
and significantly increased serum desmosterol and 
decreased serum cholesterol in individual free-
ranging black-tailed prairie dogs (Cynomys 
ludovicianus) given daily portions of about 18 g of 
a treated oat baits containing about 45 mg 
DiazaCon™ for 10 days.  
 The contraceptive potential of DiazaCon™ is 
currently being investigated in a number of 
invasive species.  Native to southern South 
America, the monk parakeet is now widely 
distributed globally. Between the late 1960s and 
early 1970s, more than 64,000 monk parakeets 
were imported into North America (Lever 1987). 
Parakeets were released both intentionally and 
unintentionally and stable populations currently 
exist in as many as 15 states in the United States 
(US, Spreyer and Bucher 1998).  Monk parakeets 
have also become established throughout the 
Caribbean, Japan, Israel, and much of Europe. 
Although the parakeet may pose a threat to local 
agriculture, the primary problem associated with 
this species in the US is the construction of large 
communal nests, woven together out of twigs and 
branches. These nests are often built in electric 
utility substations and transmission lines and can 
cause short circuits and resultant power outages 
(Avery et al. 2002, Yoder et al. 2007). In the state 
of Florida, where the population of monk parakeets 
may exceed 100,000 individuals, the threat to 
power generation and transmission equipment is of 
serious concern. DiazaCon™ administered through 
gavage to captive monk parakeets elicited increased 
desmosterol serum levels with associated decreases 
in serum cholesterol as well as significantly 
decreased egg production in studies conducted by 
the NWRC (Yoder et al. 2007).  
 The rose-ringed parakeet (Psittacula krameri) is 
another invasive parrot which has been widely 
exported for the pet trade. The species native range 
covers much of northern and central Africa as well 
as the Indian sub-continent, but rose-ringed 
parakeets have established self-sustaining 
populations in the United Kingdom (UK), Japan, 
Iran, South Africa, and the US (primarily in 
California and Florida).  Large flocks of parakeets 
can cause extensive damage to orchards and 
croplands.  
 The UK’s Central Science Laboratory (CSL), in 
cooperation with the NWRC, is currently 
researching the use of DiazaCon™ for the control of 
this species.  The CSL is also exploring DiazaCon™ 
as a means of controlling burgeoning populations 
of the eastern grey squirrel (Sciurus carolinensis).  
Introduced in the late 18th century from the eastern 
US, the grey squirrel has rapidly expanded its range 
and has displaced the native Eurasian red squirrel 
(Sciurus vulgaris) throughout much of the UK.   
 
Nicarbazin 
 Nicarbazin is an equimolar mixture of 4,4′ - 
dinitrocarbanilide (DNC) and 2-hydroxy-6,6-
dimethylpyrimidine (HDP, Figure 2). Commonly 
used as a treatment for coccidiosis in broiler 
chickens (Ott et al. 1956), nicarbazin consumption 
by laying or breeding hens causes a reduction in 
egg laying and hatchability (Jones et al. 1990, 
Hughes et al. 1991).  Although the exact 
mechanism of nicarbazin action is unclear, it may 
prevent ova from maturing (Baker et al. 1957), 
probably by affecting the structural integrity of the 
vitelline membrane (the membrane which separates 
the egg’s yolk from the albumen), allowing yolk 
and albumen to mix (Cunningham 1977, Chapman 
1994).  Decrease in egg production may be due to a 
lack of proper yolk deposition in the maturing 
follicle (Luck 1979). Yoder et al. (2006) found that  
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Figure 2.  Chemical structure of nicarbazin, an equimolar mixture of 4,4’-dinitrocarbanilimide (DNC) and 2-hydroxy-
6,6-dimethylpyrimidine (HDP). 
 
 
 
nicarbazin increased lipoprotein lipase activity and 
acted as a calcium ionophore in vitro, suggesting 
possible mechanisms for the effects observed in 
vivo. 
 By decreasing the number of eggs layed and 
overall egg hatchability, nicarbazin’s potential as 
an avian contraceptive has been extensively 
investigated. In tandem with the development of a 
palatable, nicarbazin-containing bait, analytical 
methods have been developed to confirm the 
presence of DNC in avian serum, egg yolk and 
albumin, and eggshells following ingestion of 
treated feed or baits (Johnston et al. 2001b, Primus 
et al. 2003, Stahl et al. 2003). 
 Sherwood et al. (1956) found a 10-50% 
decrease in egg fertility from leghorn hens fed 
nicarbazin in concentrations ranging from 6-700 
mg kg-1 of feed. Chickens fed varying levels of 
nicarbazin over 14 days showed positive 
correlations between amounts of nicarbazin 
consumed and residues in plasma and eggs 
(Johnston et al. 2001b), while reproductive success 
as measured by both hatchability and decreased 
reproduction rate decreased as amount of 
nicarbazin consumed increased. Yoder et al. (2006) 
demonstrated a positive dose response relationship 
between increasing levels of nicarbazin consumed 
and DNC residues in plasma, eggs, and feces of 
treated mallards.  
 A series of studies conducted at the NWRC led 
to the development of OvoControl G®, a 2500 ppm 
nicarbazin bait developed jointly by NWRC and 
Innolytics, LLC (Rancho Santa Fe, CA). When 
given to captive Canada geese (Branta canadensis), 
OvoControl G® was both well-accepted and 
effective in producing plasma DNC levels in excess 
of those found to be minimally necessary to affect 
reproduction in geese (Bynum et al. 2005, 2007).  
In field studies, free feeding of OvoControl G® to 
63 pairs of nesting Canada geese at 10 sites (5 
control, 5 treated) in Oregon resulted in a 36% 
decrease in egg hatchability when compared with 
control sites (Bynum et al. 2007).  OvoControl G® 
was subsequently registered with the US 
Environmental Protection Agency (EPA) for use 
prior to and during the breeding season to reduce 
hatching success in Canada geese. 
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 In a preliminary study using captive rock 
pigeons (Columba livia) fed a variety of nicarbazin 
formulations, Avery et al. (2006) found that a 2,500 
ppm nicarbazin bait did not significantly reduce 
egg hatchability, which may have been due to 
lower than expected plasma nicarbazin residues. A 
bait formulation of 5,000 ppm produced 
sufficiently high plasma levels to affect 
reproduction. In a subsequent study, rock pigeons 
fed 5,000 ppm baits did not exhibit reduced egg 
production, but egg viability was reduced by 59%, 
and productivity tended to be inversely correlated 
with plasma DNC concentrations. (Avery 2006). 
These results led to an EPA registration of the 
nicarbazin-containing bait, OvoControl P®, for use 
in controlling pigeon populations. 
 Nicarbazin has been investigated as a possible 
contraceptive for invasive populations of rose-
ringed parakeets in the UK, but birds gavaged with 
nicarbazin at doses ranging from 8.4 to 18 mg kg-1 
showed virtually no plasma DNC residues. 
However, DNC analysis in fecal material yielded 
high concentrations, suggesting a lack of absorption 
from the gut.  Comparative differences in psittacine 
digestive physiology may be responsible for the 
loss of nicarbazin efficacy (C. Yoder, personal 
communication). 
 
GonaConTM 
 Gonadotropin releasing hormone (GnRH) is a 
decapeptide produced by the hypothalamus and 
transported in the bloodstream to the anterior 
pituitary where it stimulates specialized cells called 
gonadotrophs to produce luteinizing hormone (LH) 
and follicle stimulating hormone (FSH).  These 
gonadotropic hormones are critical for the 
stimulation and precise timing of ovulation in 
female vertebrates and for testosterone production 
and spermatogenesis in males. Prevention of GnRH 
delivery to the pituitary gonadotrophs and 
subsequent lack of LH/FSH secretion can partially 
or completely disrupt these functions, leading to 
infertility. 
 By itself, GnRH is not immunogenic as it is 
both a natural, endogenous peptide which is not 
identified as foreign, and is simply too small to 
elicit attention from the immune system.  
Developed at the NWRC, GonaConTM is a 
contraceptive vaccine comprised of the GnRH 
decapeptide conjugated to either keyhole limpet 
hemocyanin (KLH), a large protein extracted from 
the keyhole limpet (Diodora cayenensis), or “blue 
protein” extracted from the Chilean abalone 
(Concholepas concholepas). The immunogenicity 
of the conjugate is increased by emulsifying it in 
AdjuVac™, an adjuvant also developed at the 
NWRC. AdjuVac™ is a modification of the 
Johne’s vaccine made more immunogenic by the 
addition of killed Mycobacterium avium, a common 
bacteria (Miller et al. 2004).  In rabbits, AdjuVac™ 
yielded a good immune response with fewer 
inflammatory reactions and associated tissue 
damage when compared with Freund’s Complete, a 
frequently used adjuvant (Powers et al. 2007) 
 GonaConTM is an effective contraceptive in a 
variety of species, including free-ranging California 
ground squirrels (Spermophilus beecheyi), captive 
Norway rats (Rattus norvegicus), domestic cats 
(Felis catus), domestic and feral swine (Sus scrofa), 
wild horses (Equus caballus), bison (Bison bison), 
and white-tailed deer (Odocoileus virginianus) 
[Miller et al. In Press A].  EPA registration will be 
pursued for contracepting female white-tailed deer 
(Fagerstone et al. In Press). 
 Feral pigs (Sus scrofa) have become invasive in 
38 states, with an estimated 2 million individuals in 
Texas alone and have established wild populations 
in the UK, Australia, New Zealand, and South 
America. GonaCon™ was injected into captive 
domestic pigs in one of three vaccination injection 
treatments, either 800   g, 1,600   g, or a prime 
injection (400   g) followed by a booster injection 
(400   g). In all pigs, serum antibody titers were 
highest in the 2 x 400   g injection treatment, 
followed by the 1,600   g and 800   g treatments. 
Antibody titers were inversely correlated with 
fertility and estrus suppression in sows and with 
testicular size and serum testosterone in boars 
(Miller et al. 2003). Killian et al. (2003) gave a 
single injection of either 1,000   g or 2,000   g 
GonaCon™ to penned feral pigs, and found 
reduced testicular and ovarian size as well as 
decreased serum testosterone and progesterone, all 
of which correlated with increasing antibody titers. 
Pregnancy was reduced by 90% using the 2,000   g 
dosage, while 1,000   g was sufficient to maximize 
effects in boars.  GonaCon™ is currently being 
used in a research program to contracept feral pigs 
in the UK (Massei et al. In Press). 
 Brushtailed possums (Trichosurus vulpecula) 
are native to Australia and have been introduced to 
both the UK and New Zealand.  In New Zealand, 
possums spread disease and consume native plants, 
bird eggs, and chicks.  Researchers are currently 
employing GonaCon™ to determine its 
effectiveness in contracepting possums (Eckery et 
al. In Press). 
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SpayVac™ 
 The zona pellucida (ZP) is a glycoprotein coat 
that encapsulates the ovum, and is essential for 
oocyte survival and the process of fertilization.  In 
most mammals, the ZP consists of three large 
glycoproteins, but for the purposes of 
immunocontraception the principle ZP glycoprotein 
constituent is ZP3. This glycoprotein contains 
carbohydrate groups that function as sperm 
receptors, adhering to specific proteins on the 
surface of the sperm acrosomal membrane, 
anchoring the sperm to the ZP surface, and 
initiating the process of fertilization.  
 Porcine zone pellucida (PZP) is an extracted, 
purified preparation from pig ovaries. Injection of 
PZP into non-porcine species causes an 
immunogenic reaction, stimulating the production 
of antibodies directed against the zona’s 
glycoproteins. This in turn prevents sperm from 
binding to the zona surface, resulting in infertility. 
Additionally, because the amino acid sequences of 
the zona glycoproteins are highly conserved 
between mammalian species, PZP-produced 
antibodies will frequently cross-react with the ZP 
of many other species (Killian et al. 2004). Several 
PZP preparations have been studied, but the use of 
SpayVacTM (Brown et al. 1997) emulsified in 
AdjuVacTM adjuvant yielded effective 
contraception in white-tailed deer for a period of 6 
years with a single vaccination (Miller et al. In 
Press B).  These results indicate that the preparation 
methodology used to produce SpayVacTM provides 
a “self-boosting” quality to the immunization.  
 Native species-specific ZP, non-native ZP, and 
PZP have been used to contracept a wide variety of 
species.  Rats treated with mouse zona pellucida 
exhibited a decrease in both numbers of litters and 
pups per litter (Miller et al. 1997).  Kirkpatrick et 
al. (1996) evaluated PZP in 74 species of captive 
zoo mammals and achieved successful 
contraception in 27 species from 8 families, 
including ursids, felids, mustelids, giraffids and 
bovids.  The list of species in which separate 
studies have shown PZP to provide effective 
contraception is extensive and includes African 
elephants (Loxodontia africana, Fayer-Hosken et 
al. 1999), grey seals (Halichoerus grypus, Brown 
et. al 1997), coyotes (Canis latrans, Miller et al. 
2006), burros (Equus asinus, Liu et al. 1989), and 
baboons (Dunbar et al. 1989). PZP does not appear 
to be effective in domestic cats (Gorman et al. 
2002) which may be due to large differences in 
zona proteins between the donor and recipient 
species. Currently, SpayVacTM is used to control 
overabundant species such as white-tailed deer 
(Locke et al. 2007, Miller et al. In Press B) and 
wild horses (Killian et al. 2004), but no applications 
involving invasive species have been reported. 
 One of the advantages of the immune response 
to PZP is the targeting of specific zona 
glycoproteins which do not occur elsewhere in the 
body. The PZP response is also inherently sex-
specific, as males to do not produce ZP proteins. 
Likewise, nicarbazin only affects female birds. 
Although other agents described in this paper may 
have specific action sites, they can produce more 
generalized, secondary effects which involve non-
target tissues or physiological systems, possibly 
leading to undesirable side effects. Sex-specificity 
can be readily achieved for all contraceptive 
techniques if the desired individuals can be trapped 
and treated or vaccinated, it would be far more 
difficult if contraceptive agents were broadcast 
generally in the environment through baiting. In 
many, if not most, applications involving wildlife 
contraception, appropriate baits and baiting 
techniques will be essential for the efficient 
deployment of any contraceptive agent. Chemical 
agents such as DiazaCon™ or nicarbazin are 
usually better suited to inclusion within a bait 
matrix and are routinely presented in that form, but 
for immunologically-based agents, the preservation 
of immunogenicity following consumption and 
digestion poses significant developmental 
challenges. Conjugated agents such as GonaCon™ 
may prove more amenable to this approach than 
heterogeneous preparations like SpayVac™.  
Techniques that facilitate the effective oral delivery 
of contraceptives to free-ranging wildlife are also 
under development at the NWRC.  
 Difficulties related to target specificity might be 
reduced or eliminated with the continued 
development of contraceptive agents with highly 
specific action sites. The advantages of increased 
target specificity include: (1) selection of the sex of 
the individual to be contracepted, (2) location of 
action within the body, and (3) timing of the 
intervention. A variety of new approaches which 
specifically target the oocyte are now being 
researched at the NWRC. 
 
OOCTYTE-SPECIFIC STRATEGIES 
4-vinylcyclohexene diepoxide, ERL-4221 
 As with the previous contraceptive agents 
discussed, the avenues of research being pursued by 
the NWRC include both chemical and 
immunological agents.  4-vinylcyclohexene (VCH) 
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is a byproduct in the synthesis of rubber, 
insecticides and plasticizers.  In vivo, VCH is 
metabolized to 4-vinylcyclohexene diepoxide 
(VCD, Smith et al. 1990a). Initial experiments 
showed that the administration of VCH to mice 
reduced the number of primary and secondary 
ovarian follicles (Collins and Manus 1987), but this 
effect was later found to be due to VCD following 
metabolization of VCH (Smith et al. 1990b). VCD 
ootoxicity is thought to be due to the reduced 
ability of primary and pre-antral follicles to convert 
VCD to its tetrol metabolite (Figure 3), resulting in 
follicular atresia by apoptosis (Hoyer et al. 2001).  
Intraperitoneal injection of VCD daily for 6 to 15 
days at dosages of 80-240 mg kg-1 results in 
significant or near-complete depletion of the 
ovarian oocyte pool in mice and rats (Hoyer et al. 
2001), a phenomenon which has been used to 
model menopause in humans. VCD-induced oocyte 
depletion has also been observed in cynomolgous 
macaques (Appt et al. 2006) and dogs (Miers et al. 
2005). 
 Because of various safety concerns associated 
with VCD usage, bulk production of the compound 
was terminated in 2005 (Ellis 2006).  Available 
now only as a specialty chemical, the cost of VCD 
in large quantities has become prohibitive.  For 
commercial uses, however, VCD was replaced by 
Cycloaliphatic Epoxide Resin, ERL-4221, Dow 
Chemical Co. (Figure 4). ERL-4221 is significantly 
less hazardous, but there are no reports on ERL-
4221 efficacy as an ootoxicant.  The potential of 
ERL-4221 as an oocyte-targeted contraceptive tool 
is currently being investigated by the NWRC in 
both feral pigs in cooperation with Texas A&M  
University, Kingsville, Texas, and in comparison 
with VCD in rats at NWRC headquarters in Fort 
Collins, Colorado. 
 
Growth Differentiation Factor 9, Bone 
Morphogenic Protein 15 
 The control of fertility in general and follicular 
development in particular is an extremely complex 
process that is not well understood. A wide variety 
of biochemical signals mediate communication 
between the developing oocyte and follicle and the 
ovarian granulosa cells which surround and support 
the growing follicle. One group of large, 
structurally related proteins which have been shown 
to be extensively involved in this process is the 
transforming growth factor, β  superfamily. The 
superfamily can be broken down into a number of 
subgroups, among which are the growth 
determination factors (GDF) and the bone 
morphogenic proteins (BMP). These proteins are 
macromolecules, with some as large as 450+ amino 
acid units (mers). Some twenty BMP (both 
cytokines and growth factors) have been identified 
and are thought to play important roles in 
embryonic patterning and early skeletal 
development, while some fifteen GDF have been 
characterized and have regulatory functions in the 
oocyte and virtually all developing and 
differentiating embryonic tissues.  
 During folliculogenesis, several primordial 
follicles, each containing a primary oocyte, are 
recruited for development. The oocyte increases in 
size and is encapsulated by the glycoprotein zona 
pellucida coat, and the surrounding granulosa cells 
 
 
 
 
 
 
 
Figure 3.  Chemical structure of 4-vinylcyclohexene diepoxide and its tetrol metabolite. 
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Figure 4.  Structural comparison of 4-vinylcyclohexene diepoxide (VCD) and Cycloaliphatic Epoxide Resin ERL-4221. 
 
 
 
proliferate, change shape, and begin secreting fluid, 
marking the formation of the primary follicle.  
Follicular cells continue to differentiate, while fluid 
pockets begin to form between the granulosa cells, 
marking the pre-antral stage of follicular 
development.  These fluid pockets merge, forming 
a large, liquid filled antral or secondary follicle. 
The oocyte has become many times its original 
size, and the granulosa cells which now line the 
antral cavity have also differentiated into the 
cumulus oophorous, which attaches the oocyte to 
the antral wall, and the corona radiata, comprised of 
support cells which surround the oocyte. Of the 
follicles which began this process, all but one have 
died and become atretic. The remaining follicle 
becomes pre-ovulatory in preparation for ovulation, 
followed by the resumption of meiosis in the oocyte 
and the possibility of fertilization. 
 Oocyte-produced growth factors play a critical 
role in folliculogenesis, mediating communication 
between the oocyte and granulosa/granulosa-
derived cells. Two of these factors, growth 
differentiation factor 9 (GDF9) and bone 
morphogenic protein 15 (BMP15), have been 
identified as particularly important. They interact to 
regulate proliferation and differentiation of 
granulosa cells, probably via production of inhibin 
and interaction with FSH. In most mammalian 
species, GDF9 appears to be the dominant factor as 
follicular development is completely halted in its 
absence, but both factors are usually necessary for 
successful folliculogenesis, ovulation, and 
resumption of meiosis. 
 Unlike small peptides like GnRH, successful 
development of a contraceptive vaccine using large 
macroproteins is made more difficult and expensive 
because of the sheer size of the molecule and the 
problems involved in its synthesis.  Frequently, 
however, an epitope of the macromolecule is 
recognized by the immune system, and can be 
synthesized and conjugated to a larger antigenic 
molecule.  Using the known amino acid sequences 
of both GDF9 and BMP15 in sheep, McNatty et al. 
(2006) synthesized 9 (for BMP15) or 10 (for 
GDF9) sequential, overlapping 9-15 mer epitopes 
starting from close to the carboxylic acid-
containing (c-terminal) end and progressing 
approximately 100 mer towards the amine (n)-
terminal end of each molecule to compare 
immunogenicity and contraceptive effectiveness of 
each epitope.  As with GnRH, these epitopes were 
too small to be immunogenic, so they were 
conjugated to KLH. Using these conjugates, sheep 
ewes were immunized with either anti-GDF9 or 
anti-BMP15 and the epitopes exerting the greatest 
contraceptive effectiveness were identified.  
Overall, McNatty et al. (2006) concluded that anti-
GDF9 and anti-BMP15 showed promise as 
contraceptive agents. In cooperation with New 
Zealand’s Victoria University and White Buffalo, 
Inc. (Hamden, CT), a non-profit wildlife 
management organization specializing in non-lethal 
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control of white-tailed deer, the NWRC has 
obtained and conjugated both the effective GDF9 
and BMP15 epitopes described by McNatty et al. 
(2006) and is currently exploring the use of these 
epitopes as contraceptive techniques. 
 In conjunction with the wide variety of 
contraceptive agents already developed by the 
NWRC, these new oocyte-specific contraceptive 
strategies may provide additional tools for the 
control of invasive species and other problem 
wildlife. 
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